Senior Vice President, Commercial Manufacturing · Vaxcyte, Inc. (PCVX)

Harpreet Dhaliwal

FY2021 is the first fiscal year CompBrief holds for Harpreet Dhaliwal as a named executive officer of Vaxcyte; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,844,194

Salary $93,750Stock awards $0Bonus $15,000

4th of 5 named executive officers at Vaxcyte by FY2021 total.

5 named officers on file for Vaxcyte, FY2021

Harpreet Dhaliwal’s pay file — $29

  • 1 fiscal year of pay, line by line
  • PCVX’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Vaxcyte’s whole pay program stands against its peers

  • Vaxcyte’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PCVX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 20, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Harpreet Dhaliwal’s full pay file as a PDF — free

More than this page: up to 10 years of Harpreet’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Harpreet Dhaliwal compensation by year

Vaxcyte Summary Compensation Table · the one fiscal year held
In US dollars, as Vaxcyte reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$93,750
Bonus$15,000
Stock awards$0
Option awards$1,697,710
Non-equity incentive$37,734
Pension and deferred compensation$0
All other$0
Total$1,844,194

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vaxcyte, Inc. DEF 14A filed April 20, 2022, accession 0001193125-22-111079, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Vaxcyte, Inc. filed document, accession 0001193125-22-111079. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2022.

Insider transactions since the last proxy

21 Form 4 lines since the FY2021 proxy (filed April 20, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-11-11Sale10b5-1520$68.8268,085
2026-11-11Exercise or conversion derivative10b5-117,000$0.0011,000
2026-11-11Sale10b5-19,345$68.1668,605
2026-11-11Sale10b5-17,135$67.3377,950
2026-11-11Exercise or conversion10b5-117,000$24.7985,085
2026-09-08Tax withholding—7,651$60.3668,085
2026-09-02Tax withholding—659$61.5875,736
2026-08-31Tax withholding—361$60.7476,395

The 8 most recent of 21 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Vaxcyte’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Grant PickeringChief Executive Officer$5,291,474
Andrew GuggenhimePresident and Chief Financial Officer$2,753,001
Jim WassilExecutive Vice President and Chief Operating Officer$1,970,336
Harpreet Dhaliwal · this pageSenior Vice President, Commercial Manufacturing$1,844,194
Paul SauerSenior Vice President, Process Development and Manufacturing$1,087,630

The full Vaxcyte compensation record

free company brief

This page is one person within Vaxcyte's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Vaxcyte's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Harpreet Dhaliwal's compensation dossier · One-time report. No refunds.